Bluejay Diagnostics, Inc.
BJDXNasdaqCIK 1704287HealthcareFiscal year ends Dec 31
Reports and events: 111 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1313:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-108779 |
| 2026-10-0613:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-106999 |
| 2026-09-0820:50 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-098071 |
| 2026-08-1311:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-088701 |
| 2026-08-1220:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-088347 |
| 2026-07-2221:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-080474 |
| 2026-06-0921:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-066896 |
| 2026-06-0821:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-066364 |
| 2026-06-0201:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-064363 |
| 2026-06-0200:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-064352 |
| 2026-06-0210:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-063767 |
| 2026-05-0720:13 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-053328 |
| 2026-05-0720:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-053295 |
| 2026-04-3020:00 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001213900-26-050177 |
| 2026-04-0713:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-040728 |
| 2026-03-1721:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-029261 |
| 2026-03-1610:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-027890 |
| 2026-03-1216:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-026749 |
| 2026-03-1112:54 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-025973 |
| 2026-03-1112:12 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-025962 |
| 2026-03-1110:40 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-025920 |
| 2026-03-0621:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-024616 |
| 2026-03-0614:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-024352 |
| 2026-02-2014:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-018638 |
| 2026-02-1802:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-017641 |
| 2026-01-3002:14 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-009792 |
| 2025-12-3014:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-126358 |
| 2025-11-1021:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-108192 |
| 2025-11-0721:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-107599 |
| 2025-10-1410:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-098281 |
| 2025-10-0910:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-097564 |
| 2025-08-1521:27 ET | 8-K | 8.01 Other events | 0001213900-25-077600 |
| 2025-08-1101:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-073870 |
| 2025-08-0720:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-073064 |
| 2025-07-2821:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-068296 |
| 2025-06-2022:54 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-055724 |
| 2025-06-0400:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-050913 |
| 2025-05-2821:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-048343 |
| 2025-05-1621:00 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001213900-25-044931 |
| 2025-05-1320:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-042633 |
| 2025-04-2920:00 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001213900-25-036783 |
| 2025-04-0920:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-030312 |
| 2025-03-3120:18 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-026275 |
| 2024-12-0422:26 ET | 8-K | 8.01 Other events | 0001213900-24-105693 |
| 2024-11-1811:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-099327 |
| 2024-11-0721:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-095388 |
| 2024-10-2410:59 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-090120 |
| 2024-10-1620:55 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-24-088196 |
| 2024-09-1022:04 ET | DEF 14A | Proxy statementPeriod 2024-10-23 | 0001213900-24-077413 |
| 2024-08-2821:24 ET | 8-K | 3.01 Delisting notice; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-073437 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.